Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Express Scripts Holding Co    ESRX

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Express Scripts Holding Co : quaterly earnings release

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/13/2013 | 03:15pm CEST

The company will report its earnings for Q4 2012 on 02/18/2013. Generally, the company reports earnings worse than estimates. In recent months, the 11 analysts from Thomson Reuters consensus have revised their EPS estimates downward. Below, a summary of publications and estimates for Express Scripts Holding Co.

Quarterly resultsQ1
2012
Q2
2012
Q3
2012
Q4
2012 (e)
Q1
2013 (e)
Sales
Million $
Released
Forecast
Spread
12 133
11 485
5,6%
27 693
26 541
4,3%
26 999
27 465
-1,7%

27 240

25 466
Operating income (EBITDA)
Million $
Released
Forecast
Spread
656
686
-4,3%
1 493
1 366
9,3%
1 621
1 548
4,8%

1 671

1 522
Operating profit (EBIT)
Million $
Released
Forecast
Spread
630
650
-3,1%
1 054
1 166
-9,6%
1 534
1 316
17%

1 482

1 380
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
435

364

649





Net income
Million $
Released
Forecast
Spread
268
338
-21%
171
498
-66%
391
438
-11%

499

498
EPS
 $
Released
Forecast
Spread
0,55
0,69
-21%
0,21
0,60
-65%
0,47
0,57
-18%

0,60

0,67
Announcement Date05/10/201208/07/201211/05/2012

Annual earnings per share is expected at 1.87 USD for 2012 (- 26% from 2011). A summary of annual publications and estimates is available below.

Annual results2009201020112012 (e)2013 (e)
Sales
Million $
Released
Forecast
Spread
24 749
23 995
3,1%
44 973
45 236
-0,58%
46 128
45 613
1,1%

94 051

101 169
Operating income (EBITDA)
Million $
Released
Forecast
Spread
1 608
1 678
-4,2%
2 408
2 410
-0,09%
2 658
2 683
-0,94%

5 485

6 731
Operating profit (EBIT)
Million $
Released
Forecast
Spread
1 498
1 559
-3,9%
2 164
2 224
-2,7%
2 559
2 586
-1,1%

4 790

5 816
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread










Net income
Million $
Released
Forecast
Spread
827
817
1,2%
1 181
1 201
-1,7%
1 276
1 438
-11%

1 362

2 096
EPS
 $
Released
Forecast
Spread
1,56
1,54
1,0%
2,17
2,22
-2,5%
2,53
2,83
-10%

1,87

2,82
Announcement Date02/24/201002/16/201102/22/2012

© 4-traders.com 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on EXPRESS SCRIPTS HOLDING CO
09/15 EXPRESS SCRIPTS : Mallinckrodt Pharmaceuticals - Open Letter to Mallinckrodt Emp..
09/14 EXPRESS SCRIPTS : Missouri lawmakers urge governor to rein in budget changes
09/07 EXPRESS SCRIPTS : Offers Important Prescription Drug Information for Residents I..
09/05 Express Scripts Holding Company Announces Third Quarter 2017 Earnings Confere..
08/31 EXPRESS SCRIPTS : Research Shows Significant Benefit of Adherence to Diabetes Me..
08/30 EXPRESS SCRIPTS : to Present at an Upcoming Conference
08/28 INSIDER TRADING ACTIVITY EXPRESS SCR : ESRX) – VP Sold 1,163 shares of Sto..
08/26 Health plans report progress in limiting opioid use
08/25 EXPRESS SCRIPTS : Research Shows Significant Benefit of Adherence to Diabetes Me..
08/23 EXPRESS SCRIPTS : Consent for automatic prescription refills begins Sept. 1
More news
News from SeekingAlpha
09/20 Amazon eyes pharmacy benefit sector
09/20 LEFT AND CITRON : The Boy Who Cried Wolf?
09/19 Ray Dalio's Principles & Top 7 Most Undervalued Stocks
09/19 Premarket analyst action - healthcare new coverage
09/12 Express Scripts slips on Chanos' continued bearish thesis
Financials ($)
Sales 2017 101 B
EBIT 2017 6 811 M
Net income 2017 3 117 M
Debt 2017 11 459 M
Yield 2017 -
P/E ratio 2017 11,39
P/E ratio 2018 10,34
EV / Sales 2017 0,46x
EV / Sales 2018 0,44x
Capitalization 35 230 M
Chart EXPRESS SCRIPTS HOLDING CO
Duration : Period :
Express Scripts Holding Co Technical Analysis Chart | ESRX | US30219G1085 | 4-Traders
Technical analysis trends EXPRESS SCRIPTS HOLDING CO
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 21
Average target price 67,3 $
Spread / Average Target 10%
EPS Revisions
Managers
NameTitle
Timothy C. Wentworth President, Chief Executive Officer & Director
George Paz Chairman
Christine Houston Chief Operating Officer & Executive Vice President
Eric R. Slusser Chief Financial Officer & Executive Vice President
Steven B. Miller Chief Medical Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
EXPRESS SCRIPTS HOLDING CO-8.93%35 230
WALGREENS BOOTS ALLIANCE-0.31%86 903
CVS HEALTH5.58%84 477
MCKESSON CORPORATION6.71%31 196
CARDINAL HEALTH INC-6.21%20 968
AMERISOURCEBERGEN CORP.4.36%17 371